BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 37455906)

  • 1. Exploring PANoptosis in breast cancer based on scRNA-seq and bulk-seq.
    He P; Ma Y; Wu Y; Zhou Q; Du H
    Front Endocrinol (Lausanne); 2023; 14():1164930. PubMed ID: 37455906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of PANoptosis-related predictors for prognosis and tumor microenvironment by multiomics analysis in glioma.
    Sun F; Liao M; Tao Z; Hu R; Qin J; Tao W; Liu W; Wang Y; Pi G; Lei J; Bao W; Dong Z
    J Cancer; 2024; 15(9):2486-2504. PubMed ID: 38577605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robust analysis of a novel PANoptosis-related prognostic gene signature model for hepatocellular carcinoma immune infiltration and therapeutic response.
    Wei Y; Lan C; Yang C; Liao X; Zhou X; Huang X; Xie H; Zhu G; Peng T
    Sci Rep; 2023 Sep; 13(1):14519. PubMed ID: 37666920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial DNA methylation is a predictor of immunotherapy response and prognosis in breast cancer: scRNA-seq and bulk-seq data insights.
    Ma Y; Du J; Chen M; Gao N; Wang S; Mi Z; Wei X; Zhao J
    Front Immunol; 2023; 14():1219652. PubMed ID: 37457713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of PANoptosis-related genes as prognostic indicators of thyroid cancer.
    Xie D; Huang L; Li C; Wu R; Zheng Z; Liu F; Cheng H
    Heliyon; 2024 Jun; 10(11):e31707. PubMed ID: 38845990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
    Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
    J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic analysis of PANoptosis-related genes identifies XIAP as a functional oncogene in breast cancer.
    Qi Q; Zhu M; Li P; Mi Q; Xie Y; Li J; Wang C
    Gene; 2024 Jun; 912():148355. PubMed ID: 38467314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
    Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z
    J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PANoptosis-related molecular subtype and prognostic model associated with the immune microenvironment and individualized therapy in pancreatic cancer.
    Zhang B; Huang B; Zhang X; Li S; Zhu J; Chen X; Song H; Shang D
    Front Oncol; 2023; 13():1217654. PubMed ID: 37519797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated analysis of single-cell RNA-seq and chipset data unravels PANoptosis-related genes in sepsis.
    Dai W; Zheng P; Wu J; Chen S; Deng M; Tong X; Liu F; Shang X; Qian K
    Front Immunol; 2023; 14():1247131. PubMed ID: 38239341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploration of the prognostic prediction value of the PANoptosis-based risk score and its correlation with tumor immunity in lung adenocarcinoma.
    Zhao X; Zhang X; Li F; Lu C
    J Gene Med; 2024 Mar; 26(3):e3682. PubMed ID: 38508210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PANoptosis subtypes predict prognosis and immune efficacy in gastric cancer.
    Liu Z; Sun L; Peng X; Zhu J; Wu C; Zhu W; Huang C; Zhu Z
    Apoptosis; 2024 Jun; 29(5-6):799-815. PubMed ID: 38347337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PANoptosis-based molecular clustering and prognostic signature predicts patient survival and immune landscape in colon cancer.
    Wang X; Sun R; Chan S; Meng L; Xu Y; Zuo X; Wang Z; Hu X; Han Q; Dai L; Bai T; Yu Z; Wang M; Yang W; Zhang H; Chen W
    Front Genet; 2022; 13():955355. PubMed ID: 36186438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiomics blueprint of PANoptosis in deciphering immune characteristics and prognosis stratification of glioma patients.
    Chen M; Huang M; Chen X; Lin X; Chen X
    J Gene Med; 2024 Jan; 26(1):e3621. PubMed ID: 37997255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive analysis of PANoptosome to prognosis and immunotherapy response in pan-cancer.
    Zhuang L; Sun Q; Huang S; Hu L; Chen Q
    Sci Rep; 2023 Mar; 13(1):3877. PubMed ID: 36890219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of hub genes of endothelial cells in glioblastoma-A prognostic model for GBM patients integrating single-cell RNA sequencing and bulk RNA sequencing.
    Zhao S; Ji W; Shen Y; Fan Y; Huang H; Huang J; Lai G; Yuan K; Cheng C
    BMC Cancer; 2022 Dec; 22(1):1274. PubMed ID: 36474171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The PANoptosis-related signature indicates the prognosis and tumor immune infiltration features of gliomas.
    Song J; Xu Z; Fan Q; Sun Y; Lin X
    Front Mol Neurosci; 2023; 16():1198713. PubMed ID: 37501725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PANoptosis: a potential new target for programmed cell death in breast cancer treatment and prognosis.
    Liu X; Miao M; Sun J; Wu J; Qin X
    Apoptosis; 2024 Apr; 29(3-4):277-288. PubMed ID: 38001342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Cancer-Associated Fibroblast-Related Prognostic Model in Breast Cancer via Bulk and Single-Cell RNA Sequencing.
    Hu J; Jiang Y; Wei Q; Li B; Xu S; Wei G; Li P; Chen W; Lv W; Xiao X; Lu Y; Huang X
    Biomed Res Int; 2022; 2022():2955359. PubMed ID: 36510567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pyroptosis-related gene signature predicting survival and tumor immune microenvironment in breast cancer and validation.
    Gong M; Liu X; Zhao X; Wang H
    BMC Cancer; 2022 Sep; 22(1):1005. PubMed ID: 36138348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.